drugset / Trial / NCT06619340
EXPAREL IPSA Block in Knee Arthroplasty
NaSingle-groupOpen-labelTreatment
Summary
This is a case series to assess the clinical utility of an Intra-articular Posteromedial Surgeon Administered (IPSA) Block in patients undergoing primary unilateral total knee arthroplasty.
Timeline
- Start
- 2024-05-20
- Primary completion
- 2025-05-20
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bupivacaine | Other / unclassified | 20 ml | Other |
| Background | Bupivacaine | Other / unclassified | 0.5 % | — |
| Background | Bupivacaine | Other / unclassified | 20 ml | — |